Luohe Chief Pharmaceutical

Luohe Chief Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Luohe, Henan Province, China. The company focuses on the research, development, and large-scale production of high-quality active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes small molecule therapeutics for cardiovascular health, such as Clopidogrel and Rosuvastatin, as well as anti-viral treatments like Entecavir. Operating under strict GMP compliance, the company serves as a key supplier to both domestic Chinese pharmaceutical firms and international markets. Luohe Chief Pharmaceutical is recognized for its expertise in complex chemical synthesis and its role as a contract manufacturing partner within the global pharmaceutical supply chain.